miR-199a-3p induces BRCA1 dysfunction in triple-negative breast cancer

被引:0
|
作者
Ho, John C. [1 ]
Shin, Vivian Y. [1 ]
Chen, Jiawei [1 ]
Siu, Man T. [1 ]
Cheuk, Isabella [1 ]
Kwong, Ava [1 ]
机构
[1] Univ Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1158/1535-7163.TARG-17-A046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A046
引用
收藏
页数:2
相关论文
共 50 条
  • [1] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [2] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
  • [3] The BRCA1 promoter methylation is one of the mechanisms of th BRCA1 dysfunction of triple-negative breast cancer
    Yamashita, N.
    Tokunaga, E.
    Tanaka, K.
    Saeki, H.
    Oki, E.
    Kitao, H.
    Morita, M.
    Maehara, Y.
    CANCER RESEARCH, 2013, 73
  • [4] BRCA1 methylation contributes to the triple-negative breast cancer phenotype.
    Nwachukwu, C.
    Grushko, T. A.
    Xu, J.
    Khramtsov, A.
    Olopade, O., I
    CANCER RESEARCH, 2009, 69 (02) : 266S - 266S
  • [5] Transcriptoma analyses in triple-negative breast cancer with BRCA1 germline mutation
    Nakamura, Kivvi Duarte
    Ferreira, Elisa
    Ramalho, Rodrigo
    Brianese, Rafael
    Carraro, Dirce
    CANCER RESEARCH, 2017, 77
  • [6] Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer
    Maksimenko, Jelena
    Irmejs, Arvids
    Nakazawa-Miklasevica, Miki
    Melbarde-Gorkusa, Inga
    Trofimovics, Genadijs
    Gardovskis, Janis
    Miklasevics, Edvins
    ONCOLOGY LETTERS, 2014, 7 (01) : 278 - 284
  • [7] MicroRNA-199a-3p promotes drug sensitivity in triple negative breast cancer by down-regulation of BRCA1
    Ho, John Chi-Wang
    Chen, Jiawei
    Cheuk, Isabella Wai-Yin
    Siu, Man-Ting
    Shin, Vivian Yvonne
    Kwong, Ava
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (03): : 2021 - 2036
  • [8] Prevalence of BRCA1 mutations among 284 women with triple-negative breast cancer
    Fostira, F.
    Tsitlaidou, M.
    Gogas, H.
    Pertesi, M.
    Yannoukakos, D.
    Bournakis, E.
    Karavassilis, V.
    Skarlos, P.
    Konstantopoulou, I.
    Fountzilas, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Wong-Brown, Michelle W.
    Meldrum, Cliff J.
    Carpenter, Jane E.
    Clarke, Christine L.
    Narod, Steven A.
    Jakubowska, Anna
    Rudnicka, Helena
    Lubinski, Jan
    Scott, Rodney J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 71 - 80
  • [10] Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
    Rummel, Seth
    Varner, Erika
    Shriver, Craig D.
    Ellsworth, Rachel E.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 119 - 125